VERTEX PHARMACEUTICALS INC / MA Quarterly Other Assets, Noncurrent in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Other Assets, Noncurrent history and growth rate from Q1 2010 to Q2 2024.
  • Vertex Pharmaceuticals Inc / Ma Other Assets, Noncurrent for the quarter ending June 30, 2024 was $916M, a 107% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $916M +$473M +107% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $876M +$448M +105% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $895M +$486M +119% Dec 31, 2023 10-Q 2024-08-02
Q3 2023 $475M +$343M +259% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $443M +$315M +248% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $428M +$317M +286% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $410M +$299M +270% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $133M +$57M +75.5% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $127M +$56.2M +79% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $111M +$61.4M +125% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $111M +$61.5M +125% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $75.5M -$297M -79.7% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $71.1M -$105M -59.7% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $49.3M -$111M -69.3% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $49.3M -$20.1M -28.9% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $372M +$292M +365% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $177M +$119M +206% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $161M +$122M +311% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $69.4M +$28.7M +70.4% Dec 31, 2019 10-K 2021-02-11
Q3 2019 $80M +$33.5M +72% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $57.8M +$25.1M +76.9% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $39M +$7.24M +22.8% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $40.7M +$13.3M +48.7% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $46.5M +$36M +341% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $32.7M +$22.7M +228% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $31.8M +$20.3M +177% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $27.4M +$15.5M +131% Dec 31, 2017 10-K 2019-02-13
Q3 2017 $10.5M +$540K +5.4% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 $9.94M -$4.26M -30% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $11.5M +$3.89M +51.2% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $11.9M +$4.97M +71.9% Dec 31, 2016 10-K 2018-02-15
Q3 2016 $10M -$1.06M -9.57% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 $14.2M +$5.07M +55.5% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $7.6M -$352K -4.43% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $6.91M +$3.65M +112% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $11.1M +$7.06M +177% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 $9.14M -$179K -1.92% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $7.95M -$1.5M -15.9% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $3.27M +$703K +27.4% Dec 31, 2014 10-K 2016-02-16
Q3 2014 $4M +$525K +15.1% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $9.32M +$5.03M +117% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $9.45M +$759K +8.73% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 $2.56M -$7.11M -73.5% Dec 31, 2013 10-K 2015-02-13
Q3 2013 $3.47M -$6.92M -66.6% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $4.29M -$6.12M -58.8% Jun 30, 2013 10-Q 2013-08-02
Q1 2013 $8.69M -$2.12M -19.6% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $9.67M -$1.6M -14.2% Dec 31, 2012 10-K 2014-02-11
Q3 2012 $10.4M -$3.39M -24.6% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $10.4M -$4.45M -30% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $10.8M -$4.91M -31.2% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $11.3M -$5.91M -34.4% Dec 31, 2011 10-K 2013-03-01
Q3 2011 $13.8M -$4.27M -23.7% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $14.9M +$4.54M +44% Jun 30, 2011 10-Q 2011-08-09
Q1 2011 $15.7M +$5.41M +52.5% Mar 31, 2011 10-Q 2011-05-06
Q4 2010 $17.2M Dec 31, 2010 10-K 2012-02-22
Q3 2010 $18.1M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 $10.3M Jun 30, 2010 10-Q 2010-08-03
Q1 2010 $10.3M Mar 31, 2010 10-Q 2010-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.